Both in Pharmaceuticals
Artelo Biosciences vs PMGC Holdings
Over the past year ARTL returned −97.6% and ELAB returned −99.8%; their daily moves had a correlation of 0.20.
ARTL −97.6% ELAB −99.8%Growth of $1, one year, split-adjusted
| Metric | ARTL | ELAB |
|---|---|---|
| Price | $2.33 | $2.57 |
| Market cap | $1.3M | $2.1M |
| Today | +5.91% | −0.39% |
| 1 month | −42.8% | −30.0% |
| 6 months | −92.4% | −89.8% |
| Year to date | −92.9% | −99.3% |
| 1 year | −97.4% | −99.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 29.5% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.8× |
| Net cash | $4.2M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 650.2% | 676.5% |
| Short % of float | 0.8% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).